These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27087127)

  • 1. Development of Potent and Selective Inhibitors for Group VIA Calcium-Independent Phospholipase A2 Guided by Molecular Dynamics and Structure-Activity Relationships.
    Mouchlis VD; Limnios D; Kokotou MG; Barbayianni E; Kokotos G; McCammon JA; Dennis EA
    J Med Chem; 2016 May; 59(9):4403-14. PubMed ID: 27087127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computer-aided drug design guided by hydrogen/deuterium exchange mass spectrometry: A powerful combination for the development of potent and selective inhibitors of Group VIA calcium-independent phospholipase A
    Mouchlis VD; Morisseau C; Hammock BD; Li S; McCammon JA; Dennis EA
    Bioorg Med Chem; 2016 Oct; 24(20):4801-4811. PubMed ID: 27320659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-Oxoamides based on dipeptides as selective calcium-independent phospholipase A
    Smyrniotou A; Kokotou MG; Mouchlis VD; Barbayianni E; Kokotos G; Dennis EA; Constantinou-Kokotou V
    Bioorg Med Chem; 2017 Feb; 25(3):926-940. PubMed ID: 28034646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New potent and selective polyfluoroalkyl ketone inhibitors of GVIA calcium-independent phospholipase A2.
    Magrioti V; Nikolaou A; Smyrniotou A; Shah I; Constantinou-Kokotou V; Dennis EA; Kokotos G
    Bioorg Med Chem; 2013 Sep; 21(18):5823-9. PubMed ID: 23916152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholipase A2 Isoforms as Novel Targets for Prevention and Treatment of Inflammatory and Oncologic Diseases.
    Yarla NS; Bishayee A; Vadlakonda L; Chintala R; Duddukuri GR; Reddanna P; Dowluru KS
    Curr Drug Targets; 2016; 17(16):1940-1962. PubMed ID: 26212262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Lactones: A Novel Class of Ca
    Dedaki C; Kokotou MG; Mouchlis VD; Limnios D; Lei X; Mu CT; Ramanadham S; Magrioti V; Dennis EA; Kokotos G
    J Med Chem; 2019 Mar; 62(6):2916-2927. PubMed ID: 30798607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipidomics-based assays coupled with computational approaches can identify novel phospholipase A
    Mouchlis VD; Mu C; Hammons R; Dennis EA
    Adv Biol Regul; 2020 May; 76():100719. PubMed ID: 32199750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Silico and In Vitro Study of the Bromelain-Phytochemical Complex Inhibition of Phospholipase A2 (Pla2).
    Mohamed Tap F; Abd Majid FA; Ismail HF; Wong TS; Shameli K; Miyake M; Ahmad Khairudin NB
    Molecules; 2018 Jan; 23(1):. PubMed ID: 29351216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small-molecule inhibitors as potential therapeutics and as tools to understand the role of phospholipases A
    Nikolaou A; Kokotou MG; Vasilakaki S; Kokotos G
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Jun; 1864(6):941-956. PubMed ID: 30905350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of bioactive compounds of Clematis gouriana Roxb. ex DC against snake venom phospholipase A
    Muthusamy K; Chinnasamy S; Nagarajan S; Sivaraman T; Chinnasamy S
    J Biomol Struct Dyn; 2017 Jul; 35(9):1936-1949. PubMed ID: 27355444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationship of 2-oxoamide inhibition of group IVA cytosolic phospholipase A2 and group V secreted phospholipase A2.
    Six DA; Barbayianni E; Loukas V; Constantinou-Kokotou V; Hadjipavlou-Litina D; Stephens D; Wong AC; Magrioti V; Moutevelis-Minakakis P; Baker SF; Dennis EA; Kokotos G
    J Med Chem; 2007 Aug; 50(17):4222-35. PubMed ID: 17672443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a potent 2-oxoamide inhibitor of secreted phospholipase A2 guided by molecular docking calculations and molecular dynamics simulations.
    Vasilakaki S; Barbayianni E; Leonis G; Papadopoulos MG; Mavromoustakos T; Gelb MH; Kokotos G
    Bioorg Med Chem; 2016 Apr; 24(8):1683-95. PubMed ID: 26970660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting human secretory phospholipase A2 with designed peptide inhibitors for inflammatory therapy.
    Wang P; Li Y; Shao Q; Zhou W; Wang K
    J Drug Target; 2015 Feb; 23(2):140-6. PubMed ID: 25237841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based grafting, mutation, and optimization of peptide inhibitors to fit in the active pocket of human secreted phospholipase A2: find new use of old Peptide agents with anti-inflammatory activity.
    Zhan C; Li S; Zhong Q; Zhou D
    Chem Biol Drug Des; 2015 Apr; 85(4):418-26. PubMed ID: 25187416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinguishing phospholipase A2 types in biological samples by employing group-specific assays in the presence of inhibitors.
    Lucas KK; Dennis EA
    Prostaglandins Other Lipid Mediat; 2005 Sep; 77(1-4):235-48. PubMed ID: 16099408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-affinity selective inhibitor against phospholipase A2 (PLA2): a computational study.
    Chinnasamy S; Chinnasamy S; Muthusamy K
    J Recept Signal Transduct Res; 2016; 36(2):111-8. PubMed ID: 26422703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining in silico and in vitro approaches to identification of potent inhibitor against phospholipase A2 (PLA2).
    Chinnasamy S; Selvaraj G; Selvaraj C; Kaushik AC; Kaliamurthi S; Khan A; Singh SK; Wei DQ
    Int J Biol Macromol; 2020 Feb; 144():53-66. PubMed ID: 31838071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrete roles of intracellular phospholipases A2 in human neutrophil cytotoxicity.
    Mikami S; Aiboshi J; Kobayashi T; Kojima M; Morishita K; Otomo Y
    J Trauma Acute Care Surg; 2015 Aug; 79(2):238-46. PubMed ID: 26218692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel secretory phospholipase A2 inhibitors using virtual screen.
    Qiu S; Chen F; Liu Y; Lai L
    Chem Biol Drug Des; 2014 Aug; 84(2):216-22. PubMed ID: 24612767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular dynamics simulations reveal structural insights into inhibitor binding modes and functionality in human Group IIA phospholipase A
    Kim RR; Malde AK; Nematollahi A; Scott KF; Church WB
    Proteins; 2017 May; 85(5):827-842. PubMed ID: 28056488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.